European Neuropsychopharmacology is a monthly peer-reviewed scientific journal published by Elsevier. It is the official journal of the European College of Neuropsychopharmacology. It was established in November 1990 and covers clinical and basic research relevant to the effects of centrally acting agents in its broadest sense.
According to the Journal Citation Reports, the journal has a 2020 impact factor of 4.600, ranking it 26th out of 192 journals in the category "Clinical Neurology",[1] 24th out of 140 journals in the category "Psychiatry",[2] and 31st out of 254 journals in the category "Pharmacology and Pharmacy".[3]
^"Journals Ranked by Impact: Clinical Neurology". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.{{cite book}}: CS1 maint: postscript (link)
^"Journals Ranked by Impact: Psychiatry". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.{{cite book}}: CS1 maint: postscript (link)
^"Journals Ranked by Impact: Pharmacology and Pharmacy". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.{{cite book}}: CS1 maint: postscript (link)
and 26 Related for: European Neuropsychopharmacology information
EuropeanNeuropsychopharmacology is a monthly peer-reviewed scientific journal published by Elsevier. It is the official journal of the European College...
Neuropsychopharmacology, an interdisciplinary science related to psychopharmacology (study of effects of drugs on the mind) and fundamental neuroscience...
The European College of Neuropsychopharmacology (ECNP) is a pan-European, non-profit scientific association that serves as a platform to exchange and promote...
the developmental trajectories of ADHD across the lifespan". EuropeanNeuropsychopharmacology. 28 (10): 1059–1088. doi:10.1016/j.euroneuro.2018.08.001. PMC 6379245...
in antipsychotic use: A study in 16 countries, 2005-2014". EuropeanNeuropsychopharmacology. 27 (10): 1064–1076. doi:10.1016/j.euroneuro.2017.07.001. hdl:1959...
insomnia: a review of psychopharmacology and clinical evidence". EuropeanNeuropsychopharmacology. 21 (12): 841–860. doi:10.1016/j.euroneuro.2011.04.002. PMID 21601431...
benzodiazepines in anxiety and insomnia: are they justified?". EuropeanNeuropsychopharmacology. 9 (Suppl 6): S399–405. doi:10.1016/S0924-977X(99)00051-6....
social anxiety disorder: A meta-analysis versus placebo". EuropeanNeuropsychopharmacology. 26 (6): 1062–1069. doi:10.1016/j.euroneuro.2016.02.013. PMID 26971233...
2017). "Inverse agonists - What do they mean for psychiatry?". EuropeanNeuropsychopharmacology. 27 (1): 87–90. doi:10.1016/j.euroneuro.2016.11.013. hdl:10044/1/43624...
addictive are gabapentin and pregabalin? A systematic review". EuropeanNeuropsychopharmacology. 27 (12): 1185–1215. doi:10.1016/j.euroneuro.2017.08.430. PMID 28988943...
insomnia: A review of psychopharmacology and clinical evidence". EuropeanNeuropsychopharmacology. 21 (12): 841–860. doi:10.1016/j.euroneuro.2011.04.002. PMID 21601431...
during sleep under subchronic zopiclone administration in man". EuropeanNeuropsychopharmacology. 4 (1): 21–30. doi:10.1016/0924-977X(94)90311-5. PMID 8204993...
different doses of quetiapine in schizophrenia: a PET study". EuropeanNeuropsychopharmacology. 11 (2): 105–110. doi:10.1016/S0924-977X(00)00133-4. PMID 11313155...
Global Information